Skip to main content

Psivant Therapeutics

Watertown, United States

Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.

$47.5M raised
Dec 2025
Series A

Top Investors

Samsara BioCapitalRoivant SciencesLightstone VenturesEurofarmaYK Bioventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Psivant Therapeutics

How much funding has Psivant Therapeutics raised?
Psivant Therapeutics has raised $47.5M in total funding. The most recent round was Series A. The last funding was announced in December 2025.
Who are Psivant Therapeutics's investors?
Psivant Therapeutics's investors include Samsara BioCapital, Roivant Sciences, Lightstone Ventures, Eurofarma, YK Bioventures.
Where is Psivant Therapeutics headquartered?
Psivant Therapeutics is headquartered in Watertown, United States.
What does Psivant Therapeutics do?
Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.
What stage is Psivant Therapeutics at?
Psivant Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Psivant Therapeutics — Funding & Investors." VCBacked, December 10, 2025, https://www.vcbacked.co/company/psivant-therapeutics. Accessed July 1, 2026.
APA
VCBacked. (2025). Psivant Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/psivant-therapeutics
Wikipedia (cite web)
{{cite web |title=Psivant Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/psivant-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .